Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
orphan drug
Fierce Pharma
Senate revives Orphan Cures Act in Trump's tax bill
The Senate's updated "big, beautiful bill" would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 30, 2025 10:09am
More collaborative FDA can accelerate rare disease R&D: report
Sep 13, 2024 5:00am
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Apr 24, 2024 12:01am
Pfizer punts pair of orphan drugs amid rare disease R&D rethink
Jan 31, 2023 9:15am
Stealth granted FDA meeting to revive elamipretide filing
Jun 14, 2022 10:10am
Selecta clinical hold on gene therapy lifted
Mar 10, 2022 10:44am
